Fuso Pharmaceutical Industries (TSE:4538) Research & Development: 円0 Mil (TTM As of Mar. 2026)


TSE:4538 Fuso Pharmaceutical Industries Ltd TSE:4538
51 GF Score
Price 円2,071.00
GF Value 円2,540.99
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Fuso Pharmaceutical Industries Research & Development?

Fuso Pharmaceutical Industries TSE:4538 +0.34% 51 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:4538 with a GF Score™ of 51/100 and a GF Value™ of 円2,540.99 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Fuso Pharmaceutical Industries's Research & Development for the three months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Fuso Pharmaceutical Industries  (TSE:4538) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Fuso Pharmaceutical Industries Research & Development Related Terms

Fuso Pharmaceutical Industries Research & Development Historical Data

* Premium members only.

The historical data trend for Fuso Pharmaceutical Industries's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuso Pharmaceutical Industries Research & Development Chart

Fuso Pharmaceutical Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fuso Pharmaceutical Industries Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4538
51GF Score
Fuso Pharmaceutical Industries Ltd TSE:4538
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuso Pharmaceutical Industries Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Fuso Pharmaceutical Industries (TSE:4538) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Fuso Pharmaceutical Industries and its competitors.
Is Fuso Pharmaceutical Industries' Research & Development too high?
Fuso Pharmaceutical Industries' current Research & Development is 円0 Mil. Overall, Fuso Pharmaceutical Industries has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fuso Pharmaceutical Industries' Research & Development compare to ZTS?
Fuso Pharmaceutical Industries' Research & Development of 円0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Fuso Pharmaceutical Industries and its competitors. Fuso Pharmaceutical Industries's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuso Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Fuso Pharmaceutical Industries (TSE:4538) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,540.99, compared to a current price of 円2,071.00 — trading 18.5% below its estimated fair value. The current Research & Development is 円0 Mil. Fuso Pharmaceutical Industries' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Fuso Pharmaceutical Industries (TSE:4538), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuso Pharmaceutical Industries (TSE:4538) Overvalued in 2026?

Based on GuruFocus' analysis, Fuso Pharmaceutical Industries stock appears to be undervalued. The current stock price of 円2,071.00 is trading 18.5% below its estimated GF Value™ of 円2,540.99. GuruFocus considers Fuso Pharmaceutical Industries to be Modestly Undervalued.

Key valuation signals for TSE:4538:

  • Research & Development: 円0 Mil
  • GF Value™: 円2,540.99 vs. price of 円2,071.00 (18.5% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the TSE:4538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fuso Pharmaceutical Industries Business Description

Address No. 10, No. 7-chome Doshomachi, Chuo-ku, OsaKa, JPN, 541-0045
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid. Company also includes real estate segment.
51GF Score

Get the complete analysis for TSE:4538

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,071.00
Price
円2,540.99
GF Value